(Q53987953)

23 May 2018

title

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. (English)

1 reference

23 May 2018

0 references

1 reference

1 reference

Hayashi T

1

1 reference

23 May 2018

Suzuki A

2

1 reference

23 May 2018

Shoji T

3

1 reference

23 May 2018

Togawa M

4

1 reference

23 May 2018

Okada N

5

1 reference

23 May 2018

Tsubakihara Y

6

1 reference

23 May 2018

Imai E

7

1 reference

23 May 2018

Hori M

8

1 reference

23 May 2018

publication date

1 February 2000

1 reference

23 May 2018

American Journal of Kidney Diseases

published in

1 reference

23 May 2018

volume

35

1 reference

23 May 2018

page(s)

250-256

1 reference

23 May 2018

issue

2

1 reference

23 May 2018

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Cardiovascular effects of recombinant human erythropoietin in predialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

A simple method of estimating progression of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Report on management of renal failure in Europe, XXIV, 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Hypertension and cardiovascular effects--long-term safety and potential long-term benefits of r-HuEPO

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

Trough-to-peak ratio and 24-hour blood pressure control. Methodologic issues

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970334-9

7 January 2021

10.1016/S0272-6386(00)70334-9

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

10676724

1 reference

23 May 2018